All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for INDIVIOR INC. · pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income · posted Jan 19, 2026

Official filing document

Bills named in this filing 4

HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
HR 5342
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
S 2354
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026

Lobbying activity 2

Medicare/Medicaid

Medicaid policies related to substance use disorder.

Pharmacy

Issues related to overdose reversal products including Naloxone; FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.5304/S.2587); FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.5342/S.2354).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.